Isorhamnetin: A review of pharmacological effects.
Study Design
- अध्ययन प्रकार
- Review
- जनसंख्या
- None
- हस्तक्षेप
- Isorhamnetin: A review of pharmacological effects. None
- तुलनित्र
- None
- प्राथमिक परिणाम
- None
- प्रभाव की दिशा
- Positive
- पूर्वाग्रह का जोखिम
- Unclear
Abstract
Isorhamnetin is one of the most important active ingredients in the fruits of Hippophae rhamnoides L. and the leaves of Ginkgo biloba L., which possesses extensive pharmacological activities. At present, there have been numerous investigations on isorhamnetin, which has the effects of cardiovascular and cerebrovascular protection, anti-tumor, anti-inflammatory, anti-oxidation, organ protection, prevention of obesity, etc. The related mechanisms involve the regulation of PI3K/AKT/PKB, NF-κB, MAPK and other signaling pathways as well as the expression of related cytokines and kinases. Isorhamnetin has a high value of development and application. However, the investigations on its mechanism of action are limited and lack of detailed scientific validation. The manuscript reviewed the pharmacological effects of isorhamnetin and related mechanisms of action for the development of its medicinal properties further.
संक्षेप में
The manuscript reviewed the pharmacological effects of isorhamnetin and related mechanisms of action for the development of its medicinal properties further and highlighted the need for detailed scientific validation on its mechanism of action.
Used In Evidence Reviews
Similar Papers
Journal of medicinal food · 2002
Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome.
Integrative medicine insights · 2015
Current Perspectives on the Beneficial Role of Ginkgo biloba in Neurological and Cerebrovascular Disorders.
International journal of chronic obstructive pulmonary disease · 2006
Antioxidant therapies in COPD.
Current drug targets · 2006
Antioxidant therapeutic targets in COPD.
Oxidative medicine and cellular longevity · 2017
Dietary Polyphenols in the Prevention of Stroke.
Nutrition research (New York, N.Y.) · 2022